» Articles » PMID: 23390115

Diabetic Foot Disease: Impact of Ulcer Location on Ulcer Healing

Overview
Specialty Endocrinology
Date 2013 Feb 8
PMID 23390115
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Healing of heel ulcers in patients with diabetes is considered to be poor, but there is relatively little information on the influence of ulcer location on ulcer healing.

Methods: The influence of ulcer location on time to healing of diabetic foot ulcers was analysed by multivariate Cox regression analysis for 1000 patients included in the Eurodiale study, a prospective cohort study of patients with diabetic foot disease.

Results: Median time to healing was 147 days for toe ulcers [(95% confidence interval (CI) 135-159 days)], 188 days for midfoot ulcers (95% CI 158-218 days) and 237 days for heel ulcers (95% CI 205-269 days) (p < 0.01). The median time to healing for plantar ulcers was 172 days (95% CI 157-187 days) and 155 days (95% CI 138-172 days) for nonplantar ulcers (p = 0.71). In multivariate Cox regression analysis, the hazard ratio for ulcer healing for midfoot and heel ulcers compared with toe ulcers was 0.77 (95% CI 0.64-0.92) and 0.62 (95% CI 0.47-0.83), respectively; the hazard ratio for ulcer healing for plantar versus nonplantar ulcers was 1 (95% CI 0.84-1.19). Other factors significantly influencing time to healing were the duration of diabetes, ulcer duration, the presence of heart failure and the presence of peripheral arterial disease.

Conclusions: Time to ulcer healing increased progressively from toe to midfoot to heel, but did not differ between plantar and nonplantar ulcers. Our data also indicate that risk factors for longer time to healing differ from factors that affect the ultimate number of ulcers that heal (healing rate).

Citing Articles

A Multi-Center Prospective Study on the Healing of Neuro-Ischemic Ulcers in Singapore: A Prospective Cohort Study.

Meng L, Bishnoi P, Lo Z, Yong E, Chong T, Carmody D Health Sci Rep. 2025; 8(1):e70332.

PMID: 39867718 PMC: 11758156. DOI: 10.1002/hsr2.70332.


[Development and Validation of a Risk Prediction Model for Prolonged Hospitalization in Patients With Diabetic Foot Ulcers].

Wang B, Lin T, Wu J, Gong H, Ren Y, Zha P Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(4):972-979.

PMID: 39170009 PMC: 11334298. DOI: 10.12182/20240760507.


Non-surgical treatment of diabetic foot ulcers on the dorsum of the foot with polydeoxyribonucleotide injection: Two case reports.

Ha Y, Kim J, Kim J, Kwon H World J Clin Cases. 2024; 12(20):4446-4451.

PMID: 39015916 PMC: 11235568. DOI: 10.12998/wjcc.v12.i20.4446.


A randomized, placebo-controlled study of chitosan gel for the treatment of chronic diabetic foot ulcers (the CHITOWOUND study).

Slivnik M, Navodnik Preloznik M, Fir M, Jazbar J, Lipovec N, Locatelli I BMJ Open Diabetes Res Care. 2024; 12(3).

PMID: 38909998 PMC: 11328628. DOI: 10.1136/bmjdrc-2024-004195.


Interphalangeal Resection Arthroplasty for the Prevention and Treatment of Diabetic Deformities and Ulcers of the Toes: A Systematic Review and Meta-analysis.

Yammine K, Mouawad J, Honeine M, Assi C Foot Ankle Orthop. 2024; 9(2):24730114241256373.

PMID: 38840785 PMC: 11151763. DOI: 10.1177/24730114241256373.